LivaNovaLIVN +2.94%76 Pretax Margin % is 7.59% as of Mar. 2026. GuruFocus rates LIVN with a GF Score™ of 76/100 and a GF Value™ of $62.48 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 818 Medical Devices & Instruments companies, LivaNova ranks better than 63.69% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. LivaNova's Pre-Tax Income for the
three
months ended in Mar. 2026 was $28 Mil. LivaNova's Revenue for the
three
months ended in Mar. 2026 was $362 Mil. Therefore, LivaNova's pretax margin for the quarter that ended in Mar. 2026 was 7.59%.
The historical rank and industry rank for LivaNova's Pretax Margin % or its related term are showing as below:
LIVN'
s Pretax Margin % Range Over the Past 10 Years
Min: -37.25 Med: -9.69 Max: 11.97
Current: 8.54
LIVN's Pretax Margin % is ranked better than 63.69% of 818
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs LIVN: 8.54
LivaNova (NAS:LIVN) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
LivaNova Pretax Margin % Related Terms
LivaNova Pretax Margin % Historical Data
* Premium members only.
The historical data trend for LivaNova's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LIVN vs IRTC, HAE, ITGR: Pretax Margin % Comparison
For the Medical Devices subindustry, LivaNova's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LivaNova Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LivaNova's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where LivaNova's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LivaNova (LIVN) has a Pretax Margin % of 7.59% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on LivaNova and its competitors. According to the industry distribution chart, LivaNova ranks #297 out of 818 companies in the Medical Devices & Instruments industry, placing it in the top 36.3%.
Is LivaNova's Pretax Margin % too high?
LivaNova's current Pretax Margin % is 7.59%. The Medical Devices & Instruments industry median Pretax Margin % is 2.51. LivaNova's value of 7.59% is 203% above this industry median. Based on the distribution chart, LivaNova ranks #297 out of 818 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, LivaNova has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LivaNova's Pretax Margin % compare to IRTC and HAE?
According to the Medical Devices & Instruments industry distribution chart, LivaNova ranks #297 out of 818 companies for Pretax Margin %. This puts LivaNova in the upper half of its industry. The industry median Pretax Margin % is 2.51. LivaNova's value of 7.59% is 203% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 818 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LivaNova's current Pretax Margin % of 7.59% is 203% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on LivaNova and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LivaNova's current Pretax Margin % is 7.59%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LivaNova stock overvalued right now?
Based on GuruFocus' analysis, LivaNova (LIVN) is currently considered Significantly Overvalued. The stock's GF Value™ is $62.48, compared to a current price of $83.39 — trading 33.5% above its estimated fair value. The current Pretax Margin % is 7.59% and 203% above the Medical Devices & Instruments industry median of 2.51. LivaNova's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For LivaNova (LIVN), the current Pretax Margin % is 7.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LivaNova (LIVN) Overvalued in 2026?
Based on GuruFocus' analysis, LivaNova stock appears to be overvalued.
The current stock price of $83.39 is trading 33.5% above its estimated GF Value™ of $62.48.
GuruFocus considers LivaNova to be Significantly Overvalued.
Key valuation signals for LIVN:
Pretax Margin %: 7.59%
GF Value™: $62.48 vs. price of $83.39 (33.5% above fair value)
Industry Position: 203% above the Medical Devices & Instruments median (#297 of 818)
No single metric tells the full story. See the LIVN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
76GF Score
Get the complete analysis for LIVN
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LIVN has been successfully added to your 
